Stock Events

Stock Events

Abcam 

$23.99
18
+$0.01+0.04% Tuesday 21:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
5.5B
P/E Ratio
0
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 20
$0.04
Nov 19
$0.11
Apr 19
$0.05
Nov 18
$0.11
Apr 18
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0.04
0
0.04
0.08
Expected EPS
0
Actual EPS
0.0135

Financials

4.5%Profit Margin
Profitable
2016
2017
2018
2019
2020
2021
1.07BRevenue
47.98MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABCM. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of research and diagnostic solutions, directly competing with Abcam's product offerings in antibodies and reagents.
Danaher
DHR
Mkt Cap152.13B
Danaher, through its subsidiaries like Cytiva and Pall Corporation, provides similar life sciences tools and consumables, competing in the biotechnology and research sectors.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides genomic sequencing solutions that are essential for research, competing with Abcam's offerings in the genomics and proteomics space.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies offers a broad range of analytical instruments and reagents, directly competing with Abcam in the life sciences and diagnostics markets.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products that overlap with Abcam's portfolio, especially in antibody-based technologies.
Repligen
RGEN
Mkt Cap8.39B
Repligen offers bioprocessing technologies and products that support the development of biologic drugs, competing with Abcam's solutions for drug discovery and development.
Bio-Techne
TECH
Mkt Cap9.74B
Bio-Techne operates in similar markets as Abcam, offering reagents, instruments, and custom manufacturing services for research and diagnostic applications.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in areas similar to Abcam's.
Mettler-Toledo International
MTD
Mkt Cap29.17B
Mettler-Toledo International offers precision instruments and services for research and development, competing with Abcam in the provision of lab equipment and supplies.
Waters
WAT
Mkt Cap20.81B
Waters Corporation specializes in analytical laboratory instrument and software, competing with Abcam in the life sciences sector, particularly in chromatography and mass spectrometry.

About

Health Technology
Biotechnology
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Show more...
CEO
Alan Hirzel
Employees
1682
Country
US
ISIN
US0003802040
WKN
000A2QFYM

Listings

0 Comments

Share your thoughts

FAQ

What is Abcam stock price today?▼
The current price of ABCM is $23.99 USD — it has increased by +0.04% in the past 24 hours. Watch Abcam stock price performance more closely on the chart.
What is Abcam stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Abcam stocks are traded under the ticker ABCM.
What is Abcam market cap?▼
Today Abcam has the market capitalization of 5.5B
What were Abcam earnings last quarter?▼
ABCM earnings for the last quarter are 0 USD per share, whereas the estimation was 0.19 USD resulting in a -100% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abcam revenue for the last year?▼
Abcam revenue for the last year amounts to 1.07B USD.
What is Abcam net income for the last year?▼
ABCM net income for the last year is 47.98M USD.
How many employees does Abcam have?▼
As of April 01, 2026, the company has 1,682 employees.
In which sector is Abcam located?▼
Abcam operates in the Professional, Scientific, and Technical Services sector.
When did Abcam complete a stock split?▼
Abcam has not had any recent stock splits.
Where is Abcam headquartered?▼
Abcam is headquartered in Cambridge, US.